Home > Insider Trading > Filing (0001179110-21-008283)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1109354	Bruker Corp	BRKR	Laboratory Analytical Instruments (3826)	043110160

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1133649	H Frank Laukien	C/O Bruker Corporation 40 Manning Road Billerica MA 01821	Ceo, President	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-08-16	129,284	$24.41	38,516,013	No	4	M	Direct
Common Stock	Disposition	2021-08-16	71,594	$83.83	38,444,419	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-08-16	129,284	$0.00	129,284	$24.41

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2021-10-04	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	492	Indirect	By Spouse
Common Stock	337,087	Indirect	By Son
Common Stock	336,607	Indirect	By Daughter
Common Stock	71,728	Indirect	As UTMA custodian for son
Common Stock	1,046,499	Indirect	By Former Spouse
Common Stock	201,702	Indirect	As UTMA custodian for son

Footnotes

The reporting person disclaims beneficial ownership of 1,046,499 shares held by the reporting person's former spouse, 492 shares held by the reporting person's spouse, 337,087 shares held by the reporting person's adult son and 336,607 shares held by the reporting person's adult daughter, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
Reflects shares sold to cover the Reporting Person's exercise price and tax liability in connection with the exercise of stock options.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.76 to $84.04, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.